Natural History Study of ATP1A3-related Disease
NCT03857607 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2022-06-06
Summary
An observational study aiming to study the natural history of a UK-wide patient cohort with ATP1A3-related disease.
Conditions
- ATP1A3-related Disease
- Alternating Hemiplegia of Childhood
- Rapid Onset Dystonia Parkinsonism
- CAPOS
Interventions
- GENETIC
-
Whole exome sequencing
Whole exome sequencing will be used to identify causative genes in ATP1A3 mutation negative patients, to confirm causality in ambiguous phenotypes and to identify modifier genes.
Sponsors & Collaborators
-
Great Ormond Street Hospital for Children NHS Foundation Trust
collaborator OTHER -
University College, London
collaborator OTHER -
Institute of Child Health
lead OTHER
Principal Investigators
-
Helen Cross, PhD · UCL Institute of Child Health
Eligibility
- Min Age
- 6 Months
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
STXBP1 and SYNGAP1 Related Disorders Natural History Study
NCT06555965 ·Status: RECRUITING
-
Facioscapulohumeral Dystrophy in Children
NCT02625662 ·Status: COMPLETED
-
GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO)
NCT05109793 ·Status: COMPLETED
-
Natural History Studies of Mucopolysaccharidosis III
NCT02037880 ·Status: COMPLETED
-
A Long-term Follow-up Study of Gaucher Disease
NCT03190837 ·Status: RECRUITING
-
FA Clinical Outcome Measures
NCT03090789 ·Status: ACTIVE_NOT_RECRUITING
-
Natural History Study of Participants With Sanfilippo Syndrome Type IIIC
NCT05825131 ·Status: RECRUITING
-
The Natural History Study of Patients With Sanfilippo Disease(s) (MPS3)
NCT05705674 ·Status: RECRUITING
-
Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency Patients
NCT04098211 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of the Safety and Efficacy of Late-onset Pompe Disease Gene Therapy Drug
NCT06391736 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Natural History of Rett Syndrome & Related Disorders
NCT02738281 ·Status: COMPLETED
-
SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom
NCT06504511 ·Status: RECRUITING
-
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy
NCT02603562 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)
NCT07119606 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Utility of Prenatal Whole Exome Sequencing
NCT03482141 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Pyruvate Dehydrogenase Deficiency
NCT05257005 ·Status: RECRUITING
-
An Initial Study of AZD7325 in Adults With Fragile X Syndrome
NCT03140813 ·Status: COMPLETED ·Phase: PHASE1
-
LGMD R1 Natural History Study
NCT05618080 ·Status: RECRUITING
-
AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease
NCT03533673 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I
NCT03071341 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension
NCT02531217 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Gaucherite - A Study to Stratify Gaucher Disease
NCT03240653 ·Status: RECRUITING
-
Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)
NCT06617429 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial
NCT02759952 ·Status: COMPLETED
-
A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age
NCT02484703 ·Status: TERMINATED ·Phase: PHASE2